A randomized controlled trial of two methods of oxytocin infusion administration in prevention of blood loss at caesarean sectio
Not Applicable
- Conditions
- Pregnancy and Childbirth
- Registration Number
- PACTR201909775190644
- Lead Sponsor
- Aduloju Olusola Peter
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 210
Inclusion Criteria
pregnant women with a single fetus at term >37 weeks of gestational age, with American Society of Anesthesiology (ASA) physical status I or II
Exclusion Criteria
Women at high risk for
uterine atony such as anemia (Hb <8 g/dL), multiple gestation, polyhydramnios
placenta previa,
fetal macrosomia
two or more previous CS
preeclampsia,
current or previous history of heart disease, liver, renal disorders or known coagulopathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood loss during caesarean section
- Secondary Outcome Measures
Name Time Method Post-operative blood loss, Difference in pre- and post-operative packed cell volume/ haemoglobin concentration need for additional uterotonics need for blood transfusion need for additional surgical procedures